Neurodegenerative Disorder Therapeutics Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities
Discover trends, market shifts, and competitive outlooks for the neurodegenerative disorder therapeutics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#How Has The Neurodegenerative Disorder Therapeutics Market Growth Evolved From 2024 To 2025, And What’s Ahead?#_x000D_
In recent years, the market size for therapeutics for neurodegenerative disorders has experienced significant growth. It is set to expand from $18.53 billion in 2024 to $20.04 billion in 2025, marking a compound annual growth rate (CAGR) of 8.1%. Factors that have contributed to the growth in the historic period include an aging population, an increase in cases of neurodegenerative disorders, longer life expectancy, heightened investments by pharmaceutical companies, and a rise in awareness and advocacy._x000D_
_x000D_
In the upcoming years, the neurodegenerative disorder therapeutics market is anticipated to witness robust growth, with its projected value reaching $28.33 billion in 2029, at a compound annual growth rate (CAGR) of 9.0%. Factors influencing this growth over the forecast period include the surge in demand for targeted therapy and personalized medicine, the increasing number of clinical trials, and escalating healthcare spending. Key trends during this forecast period encompass disease-altering treatments, non-drug interventions, telemedicine, and remote monitoring practices, breakthroughs in technology, precision treatments, digital healthcare solutions, and trials driven by biomarkers._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=2818&type=smp_x000D_
_x000D_
#What Are the Core Growth Drivers Propelling the Neurodegenerative Disorder Therapeutics Market Forward?#_x000D_
The rising occurrences of neurodegenerative ailments globally are fueling the growth of the market for neurodegenerative disorder treatments. The rise in elderly population is linked to a higher incidence of these disorders. For instance, data from the World Population Prospects in 2024 suggest that the population aged above 60 years will reach 2.1 billion by 2050, with those aged over 80 years almost tripling to 425 million. As per the Alzheimer’s Association, nearly 5.8 million Americans currently have Alzheimer’s disease, and this figure is expected to increase to approximately 14 million by 2050. The elevated occurrence of neurodegenerative diseases in the aging demographic accentuates the need for therapeutics for neurodegenerative disorders, thus stimulating the market for these treatments._x000D_
_x000D_
#What Segment Types Define the Neurodegenerative Disorder Therapeutics Market Structure?#_x000D_
The neurodegenerative disorder therapeutics market covered in this report is segmented –_x000D_
_x000D_
1) By Indication Type: Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types_x000D_
2) By Drug Type: N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types_x000D_
3) By Distribution: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy_x000D_
_x000D_
Subsegments:_x000D_
1) By Parkinson’s Disease: Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors, Anticholinergics_x000D_
2) By Alzheimer’s Disease: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Anti-Amyloid Monoclonal Antibodies_x000D_
3) By Multiple Sclerosis: Immunomodulators, Immunosuppressants, Corticosteroids_x000D_
4) By Huntington’s Disease: Tetrabenazine, Antipsychotic Medications_x000D_
5) By Other Indication Types: Amyotrophic Lateral Sclerosis (ALS) Treatments, Frontotemporal Dementia Treatments, Prion Disease Treatments_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=2818&type=smp_x000D_
_x000D_
#Which Geographic Areas Hold the Strongest Growth Potential in the Neurodegenerative Disorder Therapeutics Market?#_x000D_
The countries covered in the neurodegenerative disorder therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada._x000D_
_x000D_
#What Long-Term Trends Are Transforming the Competitive Landscape of the Neurodegenerative Disorder Therapeutics Market?#_x000D_
Producers of therapeutics for neurodegenerative disorders are entering into strategic partnerships with both governmental and non-governmental organizations to research and develop treatments for a wide array of neurodegenerative diseases. They are also enhancing their collaboration with other market participants to augment their research and development capabilities, with the aim of creating newer, more effective therapies for neurodegenerative disorders. For instance, NRG Therapeutics, a UK-based company that specializes in therapeutic solutions, announced a partnership with Domainex, a UK-based drug discovery service, in July 2022 to develop treatments for neurodegenerative disorders. Their collaboration would focus on creating innovative small-molecule disease-altering medications intended for the treatment of Parkinson’s disease, motor neuron disease (MND), among other debilitating ongoing neurodegenerative conditions._x000D_
_x000D_
#View the full report here:#_x000D_
_x000D_
#What Is the Definition of the Neurodegenerative Disorder Therapeutics Market?#_x000D_
Neurodegenerative disorder therapeutics refers to a medication or gene therapy to treat patients with neurodegenerative disorders therapeutically by directly rectifying pathogenic pathways, through neuroprotection, neurorestoration, and symptom control._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2818_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 3156230293_x000D_
Asia +44 2071930708_x000D_
Europe +44 2071930708_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
